ADGSOM1 & ADGMIN1  
       
  LAUNCH OF THE 50TH ANNIVERSARY CELEBRATION OF RUKUN NEGARA  
       
  KL SUMMIT 2019  
       
  HAWANA 2018  
       
  AES 2016  
       

 
 
 

April 25, 2024 -Thursday

 
 
  MOU SIGNING BETWEEN CLINICAL RESEARCH MALAYSIA (CRM) AND C&R RESEARCH INC.

Monday 16/01/2017

Clinical Research Malaysia (CRM) will be having a MoU Signing Ceremony with C&R Research Inc.

Details of the event are as follows:

Day/Date : Wednesday 18 January 2017

Time : 10:00 am – 11:00 am

Venue : Clinical Research Malaysia, Suite E-10-20, Amcorp Business Suites,
Menara Melawangi, Amcorp Trade Centre, No. 18, Jalan Persiaran Barat, 46050 Petaling Jaya, Selangor Darul Ehsan

VIPs:
- YBhg. Datuk Dr. Noor Hisham Abdullah (Director General of Health Malaysia)

- HE Mr. Yu, Hyun-seok (Ambassador of the Republic of Korea)

- YBhg. Datuk Dr. Shahnaz Murad (Deputy Director General of Health Malaysia, Research & Technical Support)

- YBrs. Dr. Goh Pik Pin (Director of the National Clinical Research Centre, Malaysia)

- Mr. Yoon, Moon-tae (Chairman, C&R Research Inc.)

- Dr. Akhmal Yusof (Chief Executive Officer, Clinical Research Malaysia)

- Mr. Lee, Dong-won (KHIDI-ASEAN Director general)

- Mr. Jung, Yun-young (KHIDI-ASEAN Researcher)

PROGRAM
10.00 am : Arrival of guests

10.10 am : Welcoming Remarks by Dr. Akhmal Yusof, CEO of Clinical Research Malaysia

10.15 am : Remarks by Mr. Yoon, Moon-tae, Chairman of C&R Research Inc.

10.20 am : Remarks by HE Mr. Yu, Hyun-seok, Ambassador of the Republic of Korea

10.25 am : Remarks by Datuk Dr. Noor Hisham, Director General of Health Malaysia.

10.35 am : MoU Signing Ceremony

11.00 am : Refreshments

You are cordially invited to send a reporter and photographer/cameraman to cover the event.

About Clinical Research Malaysia (CRM)
Established by Malaysian Ministry of Health in 2012, Clinical Research Malaysia exists to advance global health solutions for a brighter, more hopeful future for the people by providing speedy and reliable end-to-end clinical research
support for quality studies.

Our innate understanding of the local clinical research landscape with the international standards of operations coupled with fundamental backing of the government ministries provide us an incomparable advantage to work with partners from the nascent stages of development to materialisation of the end product, in order to deliver better treatment and high skilled job opportunities. For more information, please visit www.clinicalresearch.my

About C&R Research Inc., Korea
As a leading CRO, C&R Research Inc, established in 1997 has grown continuously at high growth rate with the longest history and experience in South Korea.

C&R Research, the first CRO in Korea has leaded the development of Korea CRO industry by providing excellent regulatory and clinical research services for pharmaceutical and healthcare industries encompassing clinical development phase I – III and post approval clinical studies. Additionally C&R Research has strived to provide comprehensive clinical research solutions including
e-Clinical solution, Pharmacovigilance, Centralized monitoring, QA, Medical advising and Academy.

For strategic movements, in 2010 C&R China was established in Beijing and in 2012, C&R Research joined in an Asia CRO alliance called, A-PACT (Alliance for Pac-ASIA Clinical Trials) as one of founding members. C&R Research has put effort to enter Asia and global clinical research market actively through strategic partnership and own branch offices.

Source : Clinical Research Malaysia (CRM)

FOR MORE INFORMATION, PLEASE CONTACT:
Name: Syed Hamzah Syed Noordin
Tel : 03 – 7960 5153 / 013 - 254 2542
Email : hamzah@clinicalresearch.my
Website : http://www.clinicalresearch.my

-BERNAMA
 
 
 

Copyright © 2024 MREM . All rights reserved.